Lisa Situ, PhD

Assistant Editor at Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard PhD ‘24 and proud @UCLA Bruin. Views are my own.

[Princess Margaret Cancer Centre Research @PMResearch_UHN]

Our scientists @UHN @pmcancercentre and @BCCancer discovered four new subtypes of Hodgkin lymphoma. One subtype with CSF2RB mutations creates an immune “shield”, but it can be reversed by JAK2 inhibitors, offering new treatment potential.

@CD_AACR: https://t.co/TKEtVTU8aE

[Lisa Situ, PhD @lisasitu]

@AbdelWahablab @MSKCancerCenter

[Cancer Discovery @CD_AACR]

RAF-independent MEK1-mutant Histiocytoses Respond to ERK Inhibition https://t.co/xaLr2ZmJoU
A #ResearchWatch summary of a recent study by Eli L. Diamond, Omar Abdel-Wahab, Benjamin H. Durham and colleagues.

[Cancer Discovery @CD_AACR]

Assistant Editor Lisa Situ, PhD, will attend 2025 ASCO Annual Meeting and would love to hear about your research.

Connect with her to discuss your work and learn about submitting to the journal. #ASCO25 @lisasitu

[Lisa Situ, PhD @lisasitu]

@JackFinnnerty @AmtrakNECAlerts Thanks! All on 652 got texts saying to go to ticket booth to rebook. We all go. Then the agents tell us the texts are wrong and that everything is stalled going north. Why is your messaging so bad? @Amtrak DMs tell me to expect a 30 min delay when it’s already over 1 hr late.

[Lisa Situ, PhD @lisasitu]

@AmtrakNECAlerts Can you give an update for Keystone 652?

[Lisa Situ, PhD @lisasitu]

@AmtrakNECAlerts PHL is chaos. As daily NYP<>PHL commuter, I’m used to regular Amtrak delays due to never-ending signal issues, but today’s too much. Emails, texts, signs, announcements from staff, automated announcements- all saying diff things. We’ve shifted lines 3x. And the station is dark!

[Cancer Discovery @CD_AACR]

Attending #AACRprecmed25? Assistant Editor @lisasitu, PhD, is looking forward to answering your questions about publishing in the Journal. https://t.co/SHDOTgTD4U

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

UCLA scientists identified 223 genetic mutations that drive prostate cancer evolution. Their findings, published in @CD_AACR, reveal how inherited & acquired mutations interact, offering new insights into predicting & treating aggressive cases.

https://t.co/MKxoBb4ugf

[Elizabeth McKenna @ElizSMcKenna]

Exciting news for the cancer research community! Read more about the new challenges now in @CD_AACR: https://t.co/cUdSelVGGH

[Cancer Discovery @CD_AACR]

Read this week's Cancer Discovery #ResearchWatch: https://t.co/paQPunFm3d

High-risk ER+ #BreastCancers Genomically Resemble HER2+ Tumors, a summary of the study by Kathleen Houlahan, @LiseMangiante, Cristina Sotomayor-Vivas, @alvinahere, @cncurtis, and colleagues @StanfordCancer

[Cancer Discovery @CD_AACR]

ICYMI: "Patient-Specific Hematologic Setpoints Inform Diagnosis and Prognosis" https://t.co/D2TIsidma6
A #ResearchWatch summary of a study by @foy_brody, John M. Higgins, and colleagues @uwlabmedpath @harvardmed @MassGenBrigham

[Cancer Discovery @CD_AACR]

ICYMI: "GDF-15 Blockade Overcomes Resistance to Immune Checkpoint Inhibition" https://t.co/3qi4irOY1W
A #ResearchWatch summary of a study by @DrIgMelero, Eugen Leo, and colleagues @ClinicaNavarra @CIMA_unav #visugromab #CatalYm

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Such a pleasure to meet @lisasitu Assistant Editor @CD_AACR @AACR
Her insightful questions on my talk on trial designs inspired me with new research ideas for future #PrecisionMedicine early phase combination trials! 🌟 @ElizSMcKenna @OncoAlert @KeystoneSymp #KSPrecisionOnc25

[Lisa Situ, PhD @lisasitu]

@VivekSubbiah @CD_AACR @AACR @ElizSMcKenna @OncoAlert @KeystoneSymp @oncodaily It was an honor to get the chance to speak with you! Thank you for giving such a comprehensive talk - a true highlight of #KSPrecisionOnc25 !!

[Lisa Situ, PhD @lisasitu]

Heading to Breckenridge bright and early tomorrow morning - hope to see you there! Don’t hesitate to send me a DM if you’d like to connect. Looking forward to #KSPrecisionOnc25

[Cancer Discovery @CD_AACR]

Attending @KeystoneSymp Precision Oncology: Emerging Technologies & Implementation? If you'd like to discuss your research or have questions about publishing in Cancer Discovery, please reach out to Assistant Editor Lisa Situ, PhD, during or after the meeting. #KSPrecisionOnc25

[Lisa Situ, PhD @lisasitu]

Countdown to #ASH24 ! Are you heading to San Diego this weekend? If so, I’d love to connect! If you’re presenting, please let me know ⬇️ I want to hear about your work!

[Lisa Situ, PhD @lisasitu]

@JAguirreGhiso Shout out to our wonderful freelancer @JThalappillil for the awesome write-up!!

[Lisa Situ, PhD @lisasitu]

It was our pleasure - congratulations to you and the whole team on the publication of these important findings for the field of breast cancer dormancy and metastasis!

[Elizabeth McKenna @ElizSMcKenna]

I'm so excited to be able to share this new @CD_AACR paper by @arizonaevo, @zooexoticcancer, @evilsmaug, @jdschiffman, @AthenaAktipis, Lisa Abegglen, @cmaley, @amy_boddy, and colleagues!

[Lisa Situ, PhD @lisasitu]

@GametoGen @krammecc @ASRM_org Congratulations!! Strategies to maintain fertility in the context of cancer management are so important for patients. Thank you for your contribution to moving this field forward!